Adaptive Phage Therapeutics to collaborate with Yale ’s Paul Turner Lab

APT, a biotech company, will manufacture and supply therapeutic bacteriophage for use by the Turner Lab during clinical trials.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news